Renal effects of synthetic colloids and crystalloids in patients with severe sepsis: A prospective sequential comparison

Critical Care Medicine

Volumn 39, Issue 6, 2011, Pages 1335-1342

  Bayer, Ole ^a   Reinhart, Konrad ^a   Sakr, Yasser ^a   Kabisch, Bjoern ^a   Kohl, Matthias ^a   Riedemann, Niels C ^a   Bauer, Michael ^a   Settmacher, Utz ^a   Hekmat, Khosro ^a   Hartog, Christiane S ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

acute renal failure; crystalloids; gelatin; hydroxyethyl starch; plasma substitutes; severe sepsis

Indexed keywords

GELATIN; HETASTARCH; PLASMA SUBSTITUTE;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; COLLOID; COMPARATIVE STUDY; CREATININE BLOOD LEVEL; CRYSTALLOID; DISEASE SEVERITY; FEMALE; FLUID BALANCE; FLUID INTAKE; FLUID THERAPY; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; SEPSIS;

EID: 79957655346     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318212096a     Document Type: Article

References (38)

1. Finfer S, Bellomo R, Boyce N, et al: A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350:2247-2256. (Pubitemid 38669207)
2. Perel P, Roberts I: Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2009: CD000567.
3. Dellinger RP, Levy MM, Carlet JM, et al: Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36:296-327.
4. Schortgen F, Deye N, Brochard L, et al: Preferred plasma volume expanders for critically ill patients: Results of an international survey. Intensive Care Med 2004; 30:2222-2229. (Pubitemid 40174259)
5. Basora M, Moral V, Llau JV, et al: [Perioperative colloid administration: A survey of Spanish anesthesiologists' attitudes]. Rev Esp Anestesiol Reanim 2007; 54:162-168.
6. Sakr Y, Payen D, Reinhart K, et al: Effects of hydroxyethyl starch administration on renal function in critically ill patients. Br J Anaesth 2007; 98:216-224. (Pubitemid 47072001)
7. Brunkhorst FM, Engel C, Bloos F, et al: Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358:125-139.
8. Schortgen F, Lacherade JC, Bruneel F, et al: Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: A multicentre randomised study. Lancet 2001; 357: 911-916. (Pubitemid 32247279)
9. Dart AB, Mutter TC, Ruth CA, et al: Hydroxyethyl starch (HES) versus other fluid therapies: Effects on kidney function. Cochrane Database Syst Rev 2010:CD007594.
10. Zarychanski R, Turgeon AF, Fergusson DA, et al: Renal outcomes and mortality following hydroxyethyl starch resuscitation of crit- ically ill patients: Systematic review and meta-analysis of randomized trials. Open Med 2009; 3:E196-E209.
11. Boldt J: PRO: Hydroxyethylstarch can be safely used in the intensive care patient-the renal debate. Intensive Care Med 2009; 35: 1331-1336.
12. Westphal M, James MF, Kozek-Langenecker S, et al: Hydroxyethyl starches: Different products-Different effects. Anesthesiology 2009; 111:187-202.
13. Schabinski F, Oishi J, Tuche F, et al: Effects of a predominantly hydroxyethyl starch (HES)-based and a predominantly nonHESbased fluid therapy on renal function in surgical ICU patients. Intensive Care Med 2009; 35:1539-1547.
14. Cittanova ML, Leblanc I, Legendre C, et al: Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidneytransplant recipients. Lancet 1996; 348: 1620-1622. (Pubitemid 27007061)
15. Reinhart K, Brunkhorst FM, Bone HG, et al: [Diagnosis and Therapy of Sepsis: Guidelines of the German Sepsis Society Inc. and the German Interdisciplinary Society for Intensive and Emergency Medicine]. Internist (Berl) 2006; 47:356-373.
16. Bagshaw SM, George C, Bellomo R, et al: A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients. Nephrol Dial Transplant 2008; 23: 1569-1574. (Pubitemid 351767782)
17. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41.
18. American College of Chest Physicians/ Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874.
19. Dehne MG, Mü hling J, Sablotzki A, et al: [Effect of hydroxyethyl starch solution on kidney function in surgical intensive care patients]. Anasthesiol Intensivmed Notfallmed Schmerzther 1997; 32:348-354.
20. Rioux JP, Lessard M, De Bortoli B, et al: Pentastarch 10% (250 kDa/0.45) is an independent risk factor of acute kidney injury following cardiac surgery. Crit Care Med 2009; 37:1293-1298.
21. Huter L, Simon TP, Weinmann L, et al: Hydroxyethylstarch impairs renal function and induces interstitial proliferation, macrophage infiltration and tubular damage in an isolated renal perfusion model. Crit Care 2009; 13:R23.
22. Schick MA, Isbary TJ, Schlegel N, et al: The impact of crystalloid and colloid infusion on the kidney in rodent sepsis. Intensive Care Med 2010; 36:541-548.
23. Bork K: Pruritus precipitated by hydroxyethyl starch: A review. Br J Dermatol 2005; 152:3-12.
24. Tseng MY, Hutchinson PJ, Kirkpatrick PJ: Effects of fluid therapy following aneurysmal subarachnoid haemorrhage: A prospective clinical study. Br J Neurosurg 2008; 22: 257-268. (Pubitemid 351414904)
25. Boussekey N, Darmon R, Langlois J, et al: Resuscitation with low volume hydroxyethylstarch 130 kDa/0.4 is not associated with acute kidney injury. Crit Care 2010; 14:R40.
26. Finfer S, McEvoy S, Bellomo R, et al: Impact of albumin compared to saline or organ function and mortality of patients with severe sepsis. Intensive Care Med 2011; 37:86-96.
27. Kastrup M, Markewitz A, Spies C, et al: Current practice of hemodynamic monitoring and vasopressor and inotropic therapy in post-operative cardiac surgery patients in Germany: Results from a postal survey. Acta Anaesthesiol Scand 2007; 51:347-358.
28. Engel C, Brunkhorst FM, Bone HG, et al: Epidemiology of sepsis in Germany: Results from a national prospective multicenter study. Intensive Care Med 2007; 33:606-618. (Pubitemid 46474888)
29. Hartog CS, Brunkhorst FM, Bloos F, et al: Practice of volume therapy in patients with severe sepsis: Results from a nationwide sepsis prevalence study. Intensive Care Med 2010; 36:553-554.
30. Beale R, Reinhart K, Brunkhorst FM, et al: Promoting Global Research Excellence in Severe Sepsis (PROGRESS): Lessons from an international sepsis registry. Infection 2009; 37:222-232.
31. Schortgen F, Brochard L: Colloid-induced kidney injury: Experimental evidence may help to understand mechanisms. Crit Care 2009; 13:130.
32. Mahmood A, Gosling P, Vohra RK: Randomized clinical trial comparing the effects on renal function of hydroxyethyl starch or gelatine during aortic aneurysm surgery. Br J Surg 2007; 94:427-433. (Pubitemid 46624720)
33. van der Heijden M, Verheij J, van Nieuw Amerongen GP, et al: Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Crit Care Med 2009; 37:1275-1281.
34. Verheij J, van Lingen A, Raijmakers PG, et al: Effect of fluid loading with saline or colloids on pulmonary permeability, oedema and lung injury score after cardiac and major vascular surgery. Br J Anaesth 2006; 96: 21-30. (Pubitemid 43124526)
35. Wills BA, Nguyen MD, Ha TL, et al: Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med 2005; 353:877-889. (Pubitemid 41247927)
36. Fenger-Eriksen C, Hartig Rasmussen C, Kappel Jensen T, et al: Renal effects of hypotensive anaesthesia in combination with acute normovolaemic haemodilution with hydroxyethyl starch 130/0.4 or isotonic saline. Acta Anaesthesiol Scand 2005; 49:969-974. (Pubitemid 41076340)
37. Lobo DN, Stanga Z, Aloysius MM, et al: Effect of volume loading with 1 liter intravenous infusions of 0.9% saline, 4% succinylated gelatine (Gelofusine) and 6% hydroxyethyl starch (Voluven) on blood volume and endocrine responses: A randomized, three-way crossover study in healthy volunteers. Crit Care Med 2010; 38:464-470.
38. Vincent JL, Sakr Y, Sprung CL, et al: Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006; 34: 344-353 (Pubitemid 43145611)